JPRN-jRCT2080220735未知3 期
A Double-Blind, Parallel Group, Comparative Study of Intravenous S-021812 in Patients with Influenza Virus Infection
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •The patient who diagnosed with influenza virus infection
排除标准
- 未提供
研究者
相似试验
未知
4 期
A double-blind, parallel group, comparative study of coadministration AD-4833 and SYR-322Diabetes mellitusJPRN-jRCT1080221871TAKEDA PHARMACEUTICAL COMPANY LTD.
已完成
2 期
Double-Blind, parallel-group comparison, investigators initiated phase II clinical trial of IDEC-C2B8 (Rituximab) in patients with Systemic Sclerosissystemic sclerosisJPRN-UMIN000030139The University of Tokyo Hospital56
进行中（未招募）
1 期
A study to evaluate the safety and efficacy of Seltorexant compared to Quetiapine in patients with major depressive disorder (MDD) with sleep problems who have not responded well to their current depression medicatioEUCTR2020-000341-14-GBJanssen-Cilag International NV720
进行中（未招募）
1 期
A study to evaluate the safety and efficacy of Seltorexant compared to Quetiapine in patients with major depressive disorder (MDD) with sleep problems who have not responded well to their current depression medicatioMajor Depressive Disorder (MDD)MedDRA version: 21.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSSystem Organ Class: 100000004873EUCTR2020-000341-14-BGJanssen-Cilag International NV720
进行中（未招募）
1 期
A study to evaluate the safety and efficacy of Seltorexant compared to Quetiapine in patients with major depressive disorder (MDD) with sleep problems who have not responded well to their current depression medicatioEUCTR2020-000341-14-LTJanssen-Cilag International NV720